Sanofi, Google’s Verily Launch Diabetes JV
By

Sanofi and Verily Life Sciences (formerly Google Life Sciences), an Alphabet company, have launched Onduo, a joint venture created through Sanofi and Verily’s diabetes-focused collaboration. The joint venture is based in Kendall Square in Cambridge, Massachusetts. Onduo will focus on developing solutions that combine devices, software, medicine, and professional care for disease management. The companies first announced the partnership in August 2015, 

The company will leverage Verily’s experience in miniaturized electronics, analytics, and consumer software development, and Sanofi’s clinical experience. Onduo will be led by Joshua Riff, MD, who has been appointed to chief executive officer. Dr. Riff joins Onduo from Optum, the health services company of UnitedHealth Group, where he was senior vice president of prevention and wellbeing.

Initially, Onduo will focus on the Type 2 diabetes community, specifically on developing solutions ranging from improved medication management to improved habits and goals. Over time, the company plans to expand its focus to include the Type 1 diabetes community, and eventually to people at risk of developing diabetes with the goal of helping them better prevent the onset of the disease.

Source: Sanofi

Leave a Reply

Your email address will not be published.